Literature DB >> 1443114

Selective expression of an arachidonate 12-lipoxygenase by pancreatic islet beta-cells.

V R Shannon1, S Ramanadham, J Turk, M J Holtzman.   

Abstract

The immunohistochemical distribution of arachidonate lipoxygenases in rat pancreas was characterized with specific polyclonal anti-5-lipoxygenase and anti-12-lipoxygenase antibodies. Immunohistochemical analysis of formaldehyde-fixed paraffin-embedded rat pancreas using anti-12-lipoxygenase antibody and biotin-avidin-peroxidase detection demonstrated specific staining of islets and no staining of pancreatic exocrine tissue. Less intense staining of pancreatic vascular myocytes and endothelial cells was also observed. Immunoblotting of isolated pancreatic islet extracts with the anti-12-lipoxygenase antibody demonstrated immunoperoxidase staining of a single protein band which comigrated with purified 12-lipoxygenase (relative molecular weight = 72,000) on sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis. Dispersed cells prepared from isolated islets and then subjected to fluorescence-activated cell sorting and immunostaining exhibited 12-lipoxygenase antigen in beta-cell populations but not in non-beta-cell (predominantly alpha-cell) populations. Assays of enzymatic activity confirmed that the 12-lipoxygenase-catalyzed conversion of arachidonic acid to 12-hydroxyeicosatetraenoic acid methyl ester occurred only with purified beta-cells and not with islet non-beta-cells. No evidence of 5-lipoxygenase antigen or enzymatic activity was found in purified beta-cells or in islet non-beta-cells. We conclude that rat pancreatic islet beta-cells contain an arachidonate 12-lipoxygenase which shares antigenic epitopes with the homologous enzyme contained in tissues from other species. In addition, the selective localization of the 12-lipoxygenase to pancreatic beta-cells and its absence in pancreatic acinar cells and in islet non-beta-cells support observations suggesting that 12-lipoxygenase products may participate in glucose-induced insulin secretion from beta-cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443114     DOI: 10.1152/ajpendo.1992.263.5.E828

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

2.  Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity.

Authors:  M Chen; Z D Yang; K M Smith; J D Carter; J L Nadler
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

3.  12-lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets.

Authors:  Sarah A Tersey; Bernhard Maier; Yurika Nishiki; Aarthi V Maganti; Jerry L Nadler; Raghavendra G Mirmira
Journal:  Mol Cell Biol       Date:  2014-07-28       Impact factor: 4.272

4.  Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice.

Authors:  D Bleich; S Chen; B Zipser; D Sun; C D Funk; J L Nadler
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

5.  Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes.

Authors:  Wojciech J Grzesik; Joseph L Nadler; Yui Machida; Jerry L Nadler; Yumi Imai; Margaret A Morris
Journal:  J Clin Endocrinol Metab       Date:  2014-12-22       Impact factor: 5.958

Review 6.  Minireview: 12-Lipoxygenase and Islet β-Cell Dysfunction in Diabetes.

Authors:  Sarah A Tersey; Esther Bolanis; Theodore R Holman; David J Maloney; Jerry L Nadler; Raghavendra G Mirmira
Journal:  Mol Endocrinol       Date:  2015-03-24

7.  Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction.

Authors:  David A Taylor-Fishwick; Jessica Weaver; Lindsey Glenn; Norine Kuhn; Ganesha Rai; Ajit Jadhav; Anton Simeonov; Angela Dudda; Dieter Schmoll; Theodore R Holman; David J Maloney; Jerry L Nadler
Journal:  Diabetologia       Date:  2014-11-23       Impact factor: 10.122

8.  5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue.

Authors:  René Hennig; Xian-Zhong Ding; Wei-Gang Tong; Matthias B Schneider; Jens Standop; Helmut Friess; Markus W Büchler; Parviz M Pour; Thomas E Adrian
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction.

Authors:  David A Taylor-Fishwick
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-03       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.